0,048,950 11,561,093
Operating income 10,678,524 7,031,848 11,324,920 10,160,532
Interest and financing
expenses -199,113 -399,854 -325,313 -557,561
Interest income and
other income
(expenses) 73,020 -141,491 166,151 -95,141
Income before income
taxes and non-
controlling interest 10,552,431 6,490,503 11,165,758 9,507,830
Income taxes recovery
(expense)
- Current -1,471,543 -2,579,104 -1,795,917 -3,224,439
- Deferred -690,556 970,614 -847,950 897,433
Net income for the
period 8,390,332 4,882,013 8,521,891 7,180,824
Net income
attributable to non-
controlling interest -2,581,676 -1,545,764 -2,688,556 -2,284,619
Net income
attributable to the
stockholders $5,808,656 $3,336,249 $5,833,335 $4,896,205
Net income for the
period $8,390,332 $4,882,013 $8,521,891 $7,180,824
Other comprehensive
income
Foreign currency
translation
adjustment -38,279 960,676 26,620 2,243,204
Comprehensive income 8,352,053 5,842,689 8,548,511 9,424,028
Comprehensive income
attributable to non-
controlling interest 2,583,246 1,551,187 2,695,811 2,299,930
Comprehensive income
attributable to
stockholders $5,768,807 $4,291,502 $5,852,700 $7,124,098
Earnings per share -
basic and diluted 0.14 0.08 0.14 0.12
Weighted average
number of shares
of common stock
outstanding
- Basic 42,427,503 42,851,228 42,653,223 41,983,709
- Diluted 42,431,249 43,210,296 42,653,223 42,351,756
SINOVAC BIOTE
'/>"/>SOURCE Sinovac Biotech Ltd. Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Related medicine news :1.
Sinovac to Present at the Brean Murray, Carret & Co. Fourth Investor Tour of China2.
Sinovac Provides Support to Chinas Ministry of Health to Aid Earthquake Victims3.
Sinovac Announces that Government Investigation Rules Out Healives Role in Childs Death4.
Sinovac Reports Unaudited First Quarter 2009 Financial Results5.
Sinovac Schedules 2008 Annual General Meeting6.
New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites7.
Haemacure Reports Third Quarter 2007 Results8.
First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion9.
Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best10.
MDS Reports Third Quarter 2007 Results11.
Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006